Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - NET INCOME
Net Income FATE - Fate Therapeutics, Inc.
-161 M
LAST VALUE
12.90%
2 YEAR CAGR
-19.30%
5 YEAR CAGR
-22.65%
10 YEAR CAGR